This trial is evaluating whether Imaging Panel will improve 1 primary outcome and 1 other outcome in patients with Prostate Cancer. Measurement will happen over the course of Within two years of study completion..
This trial requires 52 total participants across 1 different treatment group
This trial involves a single treatment. Imaging Panel is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
"Men with [prostate cancer](https://www.withpower.com/clinical-trials/prostate-cancer) are usually overactive and have lower sex hormone levels than men without prostate cancer. As sex hormone levels fall with age, symptoms and signs of prostate cancer tend to fade. The most common signs, however, are persistent back pain, unexplained bleeding and enlargement of the prostate gland. Diagnosis of prostate cancer is often not evident until the disease has had a long period of latency. This is why some signs, such as unexplained bleeding and back pain, do not occur at the right time for diagnosis and treatment. Once treatment starts, the body's natural hormonal state starts to shift to match what is expected from cancer treatment." - Anonymous Online Contributor
"There is no evidence that prostate cancer is curable. Even when complete clinical remission is obtained, these cases still frequently recur. Therefore, cure is inappropriate as the goal of treatment, and therapeutic intervention may only be appropriate for a period of time after a recurrent disease." - Anonymous Online Contributor
"This US study shows a prevalence of 0.8 per 1000 men over a wide age range for prostate cancer. The prevalence of prostate cancer increases with age, the higher it is over age 60 is around 1.5 per 1000 men. In men ages 45 to 75, the prevalence of prostate cancer increases linearly with advancing age. These men are most likely to be informed of their diagnosis and should have early and continuous surveillance for clinically significant disease. Prostate cancer is uncommon among African American men aged 20-60 years which is similar to what is reported in other US studies. These men, and men of their spouses are most likely to be tested for prostate cancer in clinics or by their physician." - Anonymous Online Contributor
"If [prostate cancer](https://www.withpower.com/clinical-trials/prostate-cancer) is diagnosed by an early age when treatment is available, radical prostatectomy or radiation therapy may be recommended. Prostate cancer is also highly chemo-sensitive so chemotherapy may be prescribed even when an early detection test is negative. However, only 6% of prostate cancer patients would receive adjuvant treatment." - Anonymous Online Contributor
"The correlation between prostate cancer and other diseases and its cause are a subject of debate. Data from a recent study from this study are in accordance with the findings reported from previous reports. They support that prostate cancer in the present study is correlated to diseases, lifestyle and psychological factors. Moreover, genetic, nutritional or environmental factors play significant role in its causation." - Anonymous Online Contributor
"The word "cancer" implies that a disease is terminal, that it has few and serious treatments, has an adverse prognosis, and is invariably fatal. On the other hand, cancer is one of the more prevalent diseases and is the reason that almost one million people die each year in the US. Thus, what is cancer? If we answer that question, we start to understand and treat this disease better." - Anonymous Online Contributor
"Prostate cancer patients with very high grade and stage (and most commonly those with very few lymph nodes with cancers) are very rarely likely to benefit from any treatment other than palliative care. Prostate-specific antigen values above 20 ng/mL in the presence of clinically detectable disease are indicative of a poor prognosis that usually necessitates curative treatment." - Anonymous Online Contributor
"The high proportionality and the number of the scans used in combination with the treatments for each patient justifies our choice of the Imaging Panel for patients treated with radiotherapy alone or radiotherapy combined with surgery plus adjuvant radiotherapy." - Anonymous Online Contributor
"For those who are eligible for image-guided radiation therapy (IGRT), there were no differences in treatment plan dose volumes for prostate cancer patients based on imaging panel type or dosimetric data provided; however, there was a significant increase in treatment time for those treated with the IGRT panel." - Anonymous Online Contributor
"A national study indicates that prostate cancer often presents at a younger age in the United States than has been estimated on the basis of autopsy studies, indicating that prostate cancer onset may be age dependent. This finding may have important ramifications for public health, as treatment options at younger ages may result in more effective therapeutic strategies than is the case for older men." - Anonymous Online Contributor
"A large number of prostate cancers occur in families with a hereditary background. Data from a recent study suggest screening for prostate cancer may provide a useful tool for preventing premature death from this disease." - Anonymous Online Contributor
"• This first study to illustrate the unique ways in which these common clinical scenarios are addressed in the radiology population supports the potential role of imaging as a key component of patient management of benign prostatic pathologies, of clinical complexity or difficulty." - Anonymous Online Contributor